Cargando…
Mesenchymal stem cells from bone marrow regulate invasion and drug resistance of multiple myeloma cells by secreting chemokine CXCL13
Multiple myeloma (MM) is a hematologic cancer arising from plasma cells. Mesenchymal stem cells (MSCs) are a heterogeneous cell population in the bone marrow microenvironment. In this study, we evaluated the regulatory effects of MSCs on the invasion and drug resistance of MM cells U266 and LP-1. Bo...
Autores principales: | Zhang, Guihua, Miao, Faan, Xu, Jinge, Wang, Rui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Association of Basic Medical Sciences of Federation of Bosnia and Herzegovina
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7202187/ https://www.ncbi.nlm.nih.gov/pubmed/31538911 http://dx.doi.org/10.17305/bjbms.2019.4344 |
Ejemplares similares
-
Downregulation of LEF1 Impairs Myeloma Cell Growth Through Modulating CYLD/NF-κB Signaling
por: Zhang, Guihua, et al.
Publicado: (2021) -
CXCL1, CXCL10 and CXCL12 Chemokines are Variously Expressed in Acute Myeloid Leukemia Patients Prior and Post Bone Marrow Transplantation
por: Yazdani, Bahar, et al.
Publicado: (2021) -
Adiponectin promotes human jaw bone marrow mesenchymal stem cell chemotaxis via
CXCL1 and CXCL8
por: Pu, Yinfei, et al.
Publicado: (2017) -
CXCL13 Promotes the Effect of Bone Marrow Mesenchymal Stem Cells (MSCs) on Tendon-Bone Healing in Rats and in C3HIOT1/2 Cells
por: Tian, Feng, et al.
Publicado: (2015) -
The synergized diagnostic value of VTQ with chemokine CXCL13 in lung tumors
por: Zhang, Xu, et al.
Publicado: (2023)